BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9876343)

  • 1. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes.
    Karila T; Koistinen H; Seppälä M; Koistinen R; Seppälä T
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):459-63. PubMed ID: 9876343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH.
    Kicman AT; Miell JP; Teale JD; Powrie J; Wood PJ; Laidler P; Milligan PJ; Cowan DA
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):43-50. PubMed ID: 9302371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I, IGFBP-2, and -3: do they have a role in detecting rhGH abuse in trained men?
    Di Luigi L; Guidetti L
    Med Sci Sports Exerc; 2002 Aug; 34(8):1270-8. PubMed ID: 12165681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IGF-I, IGFBP-3 and ALS concentrations and physical performance in young swimmers during a training season.
    Tourinho Filho H; Pires M; Puggina EF; Papoti M; Barbieri R; Martinelli CE
    Growth Horm IGF Res; 2017 Feb; 32():49-54. PubMed ID: 28011098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
    Wilson ME
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.
    Jørgensen JO; Vahl N; Hansen TB; Skjaerbaek C; Fisker S; Orskov H; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):479-86. PubMed ID: 9640415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
    Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
    Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum insulin-like growth factor-I in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support.
    Abribat T; Nedelec B; Jobin N; Garrel DR
    Crit Care Med; 2000 Jul; 28(7):2366-72. PubMed ID: 10921566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients.
    Musolino NR; Da Cunha Neto MB; Marino Júnior R; Giannella-Neto D; Bronstein MD
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):441-9. PubMed ID: 10468902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
    Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
    J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
    Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of restricted feeding, low-energy diet, and implantation of trenbolone acetate plus estradiol on growth, carcass traits, and circulating concentrations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in finishing barrows.
    Lee CY; Lee HP; Jeong JH; Baik KH; Jin SK; Lee JH; Sohnt SH
    J Anim Sci; 2002 Jan; 80(1):84-93. PubMed ID: 11831532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.
    Oscarsson J; Johannsson G; Johansson JO; Lundberg PA; Lindstedt G; Bengtsson BA
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):63-8. PubMed ID: 9059559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.
    Dall R; Wolthers T; Flyvbjerg A; Grøfte T; Sandahl Christiansen J; Jørgensen JO
    Horm Res; 2001; 55(2):95-101. PubMed ID: 11509866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.